Vor Biopharma Ownership | Who Owns Vor Biopharma?
Vor Biopharma Ownership Summary
Vor Biopharma is owned by 89.57% institutional investors, 9.22% insiders, and 1.21% retail investors. Tcg crossover management is the largest institutional shareholder, holding 57.47% of VOR shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.19% of its assets in Vor Biopharma shares.
VOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vor Biopharma | 89.57% | 9.22% | 1.21% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 5.67M | 57.47% | $96.50M |
| Ra capital management | 5.40M | 54.75% | $96.43M |
| Fcpm iii services b.v. | 4.12M | 41.71% | $73.45M |
| Vr adviser | 3.04M | 30.81% | $54.26M |
| Frazier life sciences management | 2.54M | 25.77% | $45.38M |
| Caligan partners lp | 1.93M | 19.50% | $34.34M |
| Paradigm biocapital advisors lp | 1.75M | 17.73% | $31.22M |
| Great point partners | 1.75M | 17.73% | $31.22M |
| Fmr | 1.54M | 15.60% | $27.47M |
| Marshall wace, llp | 1.15M | 11.68% | $20.57M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 4.12M | 10.17% | $73.45M |
| Great point partners | 1.75M | 7.18% | $31.22M |
| Rosalind advisors | 700.00K | 5.02% | $12.49M |
| Tcg crossover management | 5.67M | 2.76% | $96.50M |
| Caligan partners lp | 1.93M | 2.29% | $34.34M |
| Vr adviser | 3.04M | 2.03% | $54.26M |
| Frazier life sciences management | 2.54M | 1.17% | $45.38M |
| Ra capital management | 5.40M | 1.02% | $96.43M |
| Sphera funds management | 321.92K | 0.91% | $5.74M |
| Logos global management lp | 750.00K | 0.67% | $13.38M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 5.67M | 2.76% | 5.67M |
| Marshall wace, llp | 1.15M | 0.02% | 1.15M |
| Vr adviser | 3.04M | 2.03% | 1.10M |
| State street | 1.12M | 0.00% | 1.03M |
| Caligan partners lp | 1.93M | 2.29% | 1000.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| 5am venture management | - | - | -6.36M |
| Blackrock | 497.70K | - | -1.75M |
| Woodline partners lp | - | - | -1.11M |
| Artal group | - | - | -1.00M |
| Fmr | 1.54M | 0.00% | -986.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 5.67M | 2.76% | 5.67M | $96.50M |
| Marshall wace, llp | 1.15M | 0.02% | 1.15M | $20.57M |
| Rosalind advisors | 700.00K | 5.02% | 700.00K | $12.49M |
| Boothbay fund management | 555.70K | 0.13% | 555.70K | $9.91M |
| Braidwell lp | 466.77K | 0.28% | 466.77K | $8.33M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Point72 (difc) | -26.00 |
| Fortitude family office | -31.00 |
| Ameritas advisory services | -37.00 |
| Mai capital management | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 105 | 29.63% | 48,638,632 | 20.25% | 89 | 1.61% | 76 | 22.58% | 19 | 137.50% |
| Mar 31, 2026 | 19 | -68.85% | 2,236,902 | -91.24% | 22 | 0.02% | 16 | -60.00% | 1 | -85.71% |
| Dec 31, 2025 | 32 | -30.43% | 6,076,499 | 61.43% | 90 | 2.87% | 20 | 17.65% | 3 | -86.96% |
| Sep 30, 2025 | 45 | 9.76% | 3,764,067 | -93.40% | 56 | 2.72% | 17 | -10.53% | 22 | 100.00% |
| Jun 30, 2025 | 41 | -2.38% | 57,027,241 | 7.15% | 45 | 2.50% | 21 | 16.67% | 11 | -35.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 1.73M | 3.19% | 3.97K |
| Fidelity Growth Compy Commingled Pl O | 2.12M | 3.10% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.55M | 2.86% | 485.80K |
| Vanguard Total Stock Mkt Idx Inv | 1.55M | 2.86% | 485.80K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.55M | 2.85% | - |
| Fidelity Select Biotechnology | 1.37M | 2.54% | 189.00K |
| iShares Russell 2000 ETF | 1.03M | 1.91% | -18.34K |
| Fidelity Growth Compy Commingled Pl S | 1.96M | 1.57% | -207.80K |
| Vanguard US Total Market Shares ETF | 1.39M | 1.11% | - |
| Fidelity Growth Company Fund | 1.27M | 1.02% | -140.15K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 16, 2026 | RA CAPITAL MANAGEMENT, L.P. | - | Sell | $4.21K |
| Apr 22, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sell | $2.60M | |
| Apr 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sell | $7.46M | |
| Apr 20, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sell | $2.71M | |
| Apr 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sell | $2.46M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | - | 15 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 56 |
| 2025 Q3 | - | 14 |
VOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools